Omnitarg Breast Cancer Analysis and Forecasts to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • by BCC Research
  • February 2015
  • 123 pages

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019. This report provides: An overview of the global markets ...

Industries: Pathology | Countries: World, Japan, Europe, United States

Key Pharma News 16 FEBRUARY 2015

Key Pharma News 16 FEBRUARY 2015

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 41 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis Industry Trend Analysis - Acquisition ...

Industries: Pathology | Countries: Japan, World, United States, Russian Federation, China

World Biological Therapy: Indolent Lymphoma – Pipeline Review, H1 2012

World Biological Therapy: Indolent Lymphoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 173 pages

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Indolent Lymphoma. 'Indolent Lymphoma - Pipeline Review, ...

Industries: Pathology | Countries: World, Japan

Gaucher%s Disease - Pipeline Review, H1 2015

Gaucher%s Disease - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 86 pages

Gaucher's Disease - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Gaucher's Disease - Pipeline Review, H1 2015', provides an overview of the Gaucher's Disease's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gaucher's Disease, ...

Industries: Pathology | Countries: World, Japan

Japan Pharma  Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

Japan Pharma Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

  • $ 2 000
  • Industry report
  • by MP Advisors
  • January 2015
  • 153 pages

The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) strategies to adopt with new regulations. For the innovators ...

Industries: Pathology | Countries: Japan

Pathology in Denmark: Atrial Fibrillation – Pipeline Review, H1 2012

Pathology in Denmark: Atrial Fibrillation – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 103 pages

This report provides data on the therapeutic development for Atrial Fibrillation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Atrial Fibrillation. 'Atrial Fibrillation - Pipeline Review, ...

Industries: Pathology | Countries: World, Japan

Global Rising Stars  Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

  • $ 2 000
  • Industry report
  • by MP Advisors
  • January 2015
  • 72 pages

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The ...

Industries: Pathology | Countries: World, Japan

BML Inc. (Symbol:4694) SWOT Analysis, Strategy, Revenues and Profits

BML Inc. (Symbol:4694) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BML Inc. SWOT Analysis report provides you a strategic analysis and ...

Industries: Pathology | Countries: Japan

Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ina Research Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Philippines, Japan

R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. R-Tech Ueno, Ltd. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.